- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Several factors aid treatment selection for patients with newly diagnosed metastatic triple-negative breast cancer (TNBC), with upfront PD-L1...
Nearly half of all dementia cases in the U.S. may be linked to a dozen modifiable risk factors—most notably high blood pressure, obesity and ...
The FDA has approved nivolumab ( Opdivo ) plus platinum-doublet chemotherapy for adult patients with resectable non–small cell lung cancer ...
The combination of adjuvant abemaciclib (Verzenio) and endocrine therapy (ET) led to a clinically meaningful benefit at 3 years in patients w...
Elacestrant was found to result in a statistically significant and clinically meaningful improvement in progression-free survival over standard-o...
Although chimeric antigen receptor (CAR) T-cell treatments have shown efficacy in certain cancers, targeting multiple antigens and overcoming pro...
Patients treated with ceritinib who had ALK-positive non–small cell lung cancer with active brain metastases and/or leptomeningeal disease experi...
With a supply hitch expected to blow over soon, Novo Nordisk has high hopes for newly minted obesity med Wegovy. In fact, the company has more th...
PHOENIX — New results from a separate, larger phase 3 trial confirm the benefits ofdupilumab(Dupixent) in adults and adolescents witheosinophilic...
The FDA has granted a fast track designation to the BCMA-targeting Tri-specific T-cell Activating Construct (TriTAC), HPN217, for use as a potent...
